ArticleJournal of pain research2025
Global Epidemiology and Burden of Migraine in Children and Adolescents from 1990 to 2021: Insights from the Global Burden of Disease Study 2021.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trial
- Allergic diseases in early childhood and their association with migraine: a large-scale retrospective study.Frontiers in allergy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Migraine is the most disabling neurological disorder in children and adolescents. This study aimed to comprehensively assess the global burden of migraine in children and adolescents. Methods: Utilizing the latest data from the Global Burden of Disease (GBD) 2021, trends and disparities in incidence, prevalence, and disability-adjusted life years (DALYs) for migraine among children and adolescents were quantified by sex, age, socio-demographic index (SDI), region, and country. Decomposition analysis and frontier analyses were applied to investigate the underlying factors for changes in burden and the potential for future improvements, respectively. Results: In 2021, there were 36,794,858 new cases, 205,729,235 prevalent cases, and 7,515,775 DALYs caused by migraine in children and adolescents. From 1990 to 2021, age-standardised incidence rates (ASIR), age-standardised prevalence rates (ASPR), and age-standardised rates of DALYs (ASDR) for migraine in children and adolescents have risen, particularly among males, adolescents aged 15-19 years, regions with middle and higher SDI, East Asia, and Norway. Overall, the burden was higher in females than in males. In 2021, adolescents aged 10-14 exhibited the highest ASIR, whereas adolescents aged 15-19 had the highest ASPR and ASDR. The highest ASPR and ASDR were in low-middle SDI regions, while the highest ASIR was in high SDI regions. Tropical Latin America and Brazil had the highest ASRs regionally and nationally, respectively. Population growth and epidemiological changes drove the increase in DALYs. Regions with middle and higher SDIs hold the greatest improvement potential. Conclusion: The global burden of migraine in children and adolescents has increased substantially, disproportionately affecting females, adolescents aged 15-19 years, and low-middle SDI regions, while the greatest potential for improvement lies in middle and higher SDI regions, especially Brazil. These findings underscore the need for targeted public health policies and interventions tailored to pediatric migraine across diverse settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.